Actively Recruiting
MIGRAFIT: Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducation for Adolescents With Migraine - Randomized Controlled Trial
Led by Medical University Innsbruck · Updated on 2026-02-19
30
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Migraine is a common headache disorder in children and adolescents that can significantly impact school performance and quality of life. This research aims to evaluate a new group therapy program combining physical activity, progressive muscle relaxation (PMR), and psychoeducation tailored for young people aged 13 to 17 years with migraine. The study is a randomized controlled trial designed to assess this non-drug approach and its potential benefits. Participants are randomly assigned to one of two groups: the intervention group receives an 18-week program with weekly 65-minute group sessions including high-intensity interval training (HIIT) followed by PMR, plus two psychoeducation sessions focused on pain management. The control group does not receive any intervention during this time. This design allows comparison of the combined therapy against no treatment. During the study, participants will track their migraine frequency, duration, intensity, and medication use using standardized headache diaries before and after the intervention. Additional assessments include measuring migraine-related disability with a questionnaire and analyzing physical activity patterns in some participants. The study will also evaluate how feasible and acceptable the therapy is from the patient perspective. Total participation covers the treatment and observation period up to 4 weeks after enrollment.
CONDITIONS
Brief Title
MIGRAFIT: Evaluating a Group Therapy Program Combining Physical Activity, Progressive Muscle Relaxation and Psychoeducation for Adolescents With Migraine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed migraine according to the International Classification of Headache Disorders, 3rd edition (ICHD-3)
- Age between 13 and 17 years
- Residence within 35 kilometers of the study site or daily commute nearby for school or work
You will not qualify if you...
- Taking continuous preventive medication for migraine
- Changed migraine medication within the past 4 weeks
- Psychiatric or physical conditions that interfere with weekly group therapy participation including physical activity
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants engage in weekly group therapy sessions combining high-intensity interval training, progressive muscle relaxation, and psychoeducation focusing on pain management.
Weekly visits for 4 weeks
Trial Site Locations
Total: 1 location
1
Department of Pediatric and Adolescent Medicine
Innsbruck, Tyrol, Austria, 6020
Actively Recruiting
Research Team
C
Christian Lechner, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here